Off-Label TAVI Associates With Higher Risk for Poor Outcomes

TAVI for off-label indications is associated with increased risk for poor outcomes, such as mortality and stroke, compared with guideline-directed-TAVI.

Related Keywords

Boston ,Massachusetts ,United States ,Johnh Stroger Jr ,Thomas Jefferson University Hospital ,National Readmission Database ,Transcatheter Cardiovascular Therapeutics ,Scientific Symposium ,Johnh Stroger Jr Hospital ,Cook County ,National Readmission ,